New research has revealed a previously unknown biological process through which breast tumor cells develop resistance to standard treatment, which could open the door for cancer scientists around the world to further target this vulnerability in hopes of creating more effective therapies for disease. Additionally, the research team tested a promising drug in combination with an existing therapy that achieved total remission in one breast cancer model that was resistant to the standard of care, and reduced cancer growth by nearly 70% in other models of advanced disease.